Immunological system status and the appearance of respiratory system disturbances in thymectomized patients by Krawczyk, Paweł et al.
Arch. Immunol. Ther. Exp., 2007, 55, 49–56 DOI  10.1007/s00005-007-0004-z
PL ISSN 0004-069X
Immunological system status 
and the appearance of respiratory system disturbances 
in thymectomized patients
Paweł Krawczyk1, Marta Adamczyk−Korbel1, Robert Kieszko1, Elżbieta Korobowicz2
and Janusz Milanowski1
1 Department of Pneumonology, Oncology, and Allergology, Medical University of Lublin, Poland
2 Department of Pathomorphology, Medical University of Lublin, Poland
Received: 2006.01.02, Accepted: 2006.10.06, Published online first: 2007.02.02
Abstract
Introduction: Adult-onset thymoma may be responsible for several diseases, such as pure red cell aplasia, myasthenia gravis,
and immunodeficiency (Good’s syndrome). Thymectomy does not always improve the patient’s condition, and may even pro-
duce additional symptoms. Its pathogenesis is still not entirely understood, but autoimmunological processes and bone mar-
row defect are the most frequently suggested.
Materials and Methods: Eleven patients (mean age: 56.2±15.5 years) were analyzed 6 months to 10 years after thymectomy
due to thymoma as were 25 healthy persons serving as controls. Enzyme-linked immunosorbent assay (ELISA) and flow
cytometry techniques were used to evaluate the immunological status of the subjects.
Results: Good’s syndrome was diagnosed in one patient, 4 subjects suffered from myasthenia gravis, and recurrent infections
of upper and lower respiratory tract appeared in 9 patients. The immunological analyses (ELISA and flow cytometry)
revealed a significantly lower IgG level (p<0.05), percentage of peripheral blood B lymphocytes (p<0.0005), and CD4:CD8
ratio (p<0.05) in thymectomized patients compared with the healthy controls. The percentages of CD4+ and CD8+ T lym-
phocytes expressing CD28 antigen were significantly lower in thymectomized patients than in healthy subjects (p<0.005 and
p<0.01, respectively). The percentage of naïve T helper lymphocytes was significantly lower in the patients than in the control
group (p<0.05).
Conclusions: Immunodeficiency and recurrent infections may be the first symptoms of immunological disturbances after
thymectomy in adults. It is suggested that regular medical monitoring of these patients is important in preventing further
complications, which may result in irreversible lung tissue destruction.
Key words: thymectomy, immunodeficiency, respiratory infections.
Abbreviations:  AChR – acetylocholine receptor, CVID – common variable immunodeficiency, ELISA – enzyme-linked
immunosorbent assay, FEF25, FEF50, FEF75 – forced expiratory flow at 25, 50, and 75% of vital capacity, FEV1 – one-sec-
ond forced expiratory volume, GS – Good’s syndrome, MG – myasthenia gravis, PBL – peripheral blood lymphocyte, PFT –
pulmonary function test, PRCA – pure red cell aplasia, TCR – T cell receptor, Th – T-helper, TRECs – TCRδ excision cir-
cle, VC – vital capacity.
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INTRODUCTION
For centuries the thymus remained an enigmatic
organ of unknown function. The first demonstration of
its crucial role in establishing the development of a nor-
mal immune system was provided in 1961 when it was
shown that mice thymectomized immediately after birth
had poorly developed lymphoid tissue, impaired immune
responses, and an inordinate susceptibility to recurrent
infections [11]. The role of thymus in T cell development
and in the postnatal lymphocyte developmental stages is
currently being investigated. The precursors that give
rise to T cells leave the bone marrow and migrate to the
thymus for their differentiation. T cell development inthe thymus is divided into two main stages. The first is
independent of the T cell receptor (TCR), while the sec-
ond is completely dependent on the TCR and its inter-
action. Immature thymocytes in the first stage do not
express any definitive T cell markers. These are CD4 and
CD8 double-negative early thymocytes. These cells
migrate through the thymic cortex, proliferating exten-
sively and acquiring new surface markers. The first intra-
cellular TCR proteins, products of successful TCR gene
rearrangement, are seen at the end of the first develop-
mental stage. Cells that succeed in expressing TCRγ and
TCRδ proteins develop into mature TCRγδ. If they are
successful in TCRβ rearrangement, the TCRβ+ cells are
rewarded by proliferation and differentiation into CD4
and CD8 double-positive cells. These cells, the precur-
sors of conventional TCRαβ T lymphocytes, go on to
rearrange their TCRα genes and undergo positive and
negative selection for self/non-self discrimination
through the engagement of TCR with peptide present in
a major histocompatibility complex on antigen-present-
ing cells. Mature thymocytes differentiate into CD4 or
CD8 single-positive T cells. After positive selection and
maturation, T lymphocytes finally exit the thymus to take
up their roles in the immune system [17].
The destruction of the thymic structure in the course
of thymoma is responsible for immunological distur-
bances in the selection and maturation of T cells. Adult
onset of thymoma may be the cause of several autoim-
munological diseases, such as pure red cell aplasia
(PRCA), myasthenia gravis (MG), alopecia areata, and
Sjögren’s syndrome [8]. Good’s syndrome (GS), first
described in 1954, is a rare condition characterized by
recurrent infection in the course of thymoma and
immunodeficiency [3]. A typical patient affected by GS
is in their fifties to seventies and develops recurrent
bronchitis, sinusitis, or pneumonia which may be com-
plicated with bronchiectasis. Systemic symptoms such as
weight loss, fatigue, chronic diarrhea, and dermatitis are
common. Immunodeficiency in GS is characterized by
a low number of peripheral blood B cells, or even their
absence, and hypogammaglobulinemia. These distur-
bances may be derivative of defects in cell-mediated
immunity, manifested by CD4+ T-lymphopenia and an
inverted CD4:CD8 ratio. Thymectomy does not always
improve the patient’s condition, and may even produce
additional symptoms. The pathogenesis of the phenom-
enon is still not entirely understood [22].
The aim of the study was to determine immunologi-
cal disturbances in patients after thymectomy. We
searched for evidence that removal of the thymus may
be responsible for several abnormalities of the respira-
tory system. We suggest that immunodeficiency and res-
piratory system disturbances may be common in
thymectomized patients.
MATERIALS AND METHODS
We analyzed four men and seven women (mean age:
56.2±15.5 years, range: 27–76 years) 6 months to 10 years
(mean: 60.4±35.2 months) after thymectomy due to thy-
moma. Since then, tumor recurrence had not been
detected in any case. Appropriate treatment (chemother-
apy and/or radiotherapy) was applied only in patients
with malignant thymoma.
Thymoma, the most common primary tumor of the
anterior mediatsinum, is pathologically an epithelial neo-
plasm characterized by an admixture of epithelial cells
and mature lymphocytes [21]. The thymomas were classi-
fied according to the recent World Health Organization
(WHO) classification as WHO type A and AB thymomas
(medullary and mixed thymomas), type B thymomas
(predominantly cortical and cortical thymomas and well-
-differentiated thymic carcinomas), and type Cthymomas
(category II malignant thymomas) [14].
The diagnosis of respiratory infection susceptibility
was based on patient history and a physical examination,
routine serum biochemical and hematological tests,
chest and sinus X-rays, pulmonary function tests
(PFTs), and a sputum microbiological analysis. Lung
function parameters, including the one-second forced
expiratory volume (FEV1), vital capacity (VC), and
forced expiratory flow at 25%, 50%, and 75% of VC,
were measured with a pneumotachograph (ABC-Med,
Kraków, Poland). The values obtained were expressed
as percentages of the predicted normal values.
FEV1%VC was also evaluated. Airflow obstruction was
defined as FEV1%VC below 0.7 with VC above 80%.
Restriction was defined as VC below 80% and FEV1
below 80% with FEV1%VC above 0.7. Small airflow
obstruction was defined as FEF50 below 60% with
FEV1%VC above 0.7 and VC and FEV1 above 80%.
Mixed-type PFT disturbances was defined as FEV1%VC
below 0.7, VC and FEV1 below 80%.
The diagnosis of MG was based on clinical features,
decrement testing on 3-Hz serial stimulation, and the
detection of anti-acetylocholine receptor (AchR) auto-
antibodies. Good’s syndrome was diagnosed based on
clinical symptoms as well as measurements of the gam-
maglobulin level and the peripheral blood B cell per-
centage and count.
Protein electrophoresis, a lymphocyte subtype cyto-
metric analysis, and the ELISA for serum immunoglobu-
lin level analysis were performed to detect immunological
disturbances. Three-color flow cytometry was used to
establish peripheral blood lymphocyte (PBL) subtypes.
The following directly conjugated monoclonal antibodies
were used: Simultest (Becton Dickinson), mouse anti-
-human CD4 FITC, CD8 PerCP, CD28 PE, CD45RO
PE, and CD45RA PE (Becton Dickinson, Pharmingen).
Immunnofluorescent staining was performed according
to the manufacturer’s protocol using Lysing Solution
(Becton Dickinson) for erythrocyte elimination. Cells
were collected in aFACS Calibur flow cytometer (Becton
Dickinson) and their phenotype analyzed using Cell
Quest Software. The results of steroid-treated patients
were not significantly different in any of the assays. The
tests were performed before immunoglobulin supple-
mentation in the patient with GS. 
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age: 49.2±10.7 years, range: 23–66 years) matched for
sex and age were studied as controls. The study was per-
formed with the approval of the Ethics Committee of
the Medical University of Lublin.
Both descriptive and analytical statistical methods
were used to analyze the data. Statistical analysis was
performed using the non-parametric Mann-Whitney
U-test and Spearman’s correlation test as well as Statis-
tica 5.0 software. The statistical tests used a two-sided
level of significance of 0.05.
RESULTS
The clinical data are summarized in Table 1. Of the
thymectomized patients, 36.4% (n=4) suffered from
MG. The symptoms of myasthenia occurred prior to
thymectomy in two patients. Myasthenia appeared
three months and one year after thymectomy in the two
other patients. Recurring or acute infections of the
upper and lower respiratory tract appeared in 81.8%
(n=9) of the thymectomized patients. Chronic diarrhea
following respiratory infections was seen in two
patients. Good’s syndrome was diagnosed in one
patient examined.
Thickening of the maxillary sinus mucosa and
a reduction in sinus airspace was ascertained in 5
thymectomized patients. In the patient with GS, these
coexisted with infiltration in the superior and middle
fields of the left lung and with pleural adhesions at the
left lung base, as could be seen in the chest radiograph.
Bilateral ground-glass opacities and diffuse areas of
condensation as well as infiltration in the lingual of the
left lung with mediastinal displacement dominated in
the computed tomography chest scan of this patient. In
another patient, bilateral pleural effusion and pericar-
dial effusion were showed in the chest X-ray. In all
patients, the features of the thymectomy were seen in
the chest radiograph.
For all the examined patients the mean spirometric
values were in the normal range (FEV1 73.2±22.33%,
VC 86.0±22.0%, FEV1/VC 0.87±0.18, FEF25
76.8±38.93%, FEF50 68.3±35.78%, FEF75
68.2±34.78%). We found 5 patients with restriction,
including two subjects with MG and one patient with
GS. In one patient, PFT disturbances of the obstruction
type were determined. Two subjects were affected by
small airway disease.
Microbiological analysis of the sputum samples was
performed in 6 patients. The cultures of sputum yielded
Streptoccocus viridans (5 patients), Candida sp.
(6 patients), Streptococcus alfa (1 patient), Neisseria sp.
(3 patients), Citrobacter koseri (1 patient), Citrobacter
braaki  (the GS patient), Haemophilus parainfluenze
(2 patients), and Escherichia coli (1 patient). Tests for
HIV infection were negative.
The mean results of the routine hematological and
biochemical tests of the thymectomized patients did not
differ significantly from those of the healthy controls,
with the exception of the total number and the subtypes
of peripheral blood leukocytes. The total number of
leukocytes and granulocytes was significantly higher
(p<0.05) in the thymectomized patients than in the con-
trol subjects. The number and percentage of peripheral
blood eosinophils were significantly lower (p<0.05 and
p<0.0005, respectively) in the examined patients
(89±87 cells/µl and 0.84±0.96%, respectively) than in
the healthy controls (191±149 cells/µl and 2.46±1.05%,
respectively). Laboratory tests of the GS patient demon-
strated a low level of total serum protein (4.9 g/dl) due
to a reduction in the percentage and the level of beta-
and gammaglobulins (2.9%, 0.16 g/dl and 3.3%, 0.18
g/dl, respectively).
For all the thymectomized patients, the mean level
of serum immunoglobulin was within the normal range.
Lack of immunoglobulins was characteristic of the
patient with GS. The mean concentration of IgG was
significantly lower and the level of IgM significantly
higher in the thymectomized patients than in the healthy
subjects (p<0.05; Tables 2 and 3).
The percentage and number of peripheral blood
B lymphocytes (CD19+ cells) was significantly lower
(p<0.0005) and the percentage of T lymphocytes
(CD3+ cells) significantly higher (p<0.01) in thymec-
tomized patients than in the healthy subjects.
Cytometric analysis revealed a higher percentage of
cytotoxic-suppressor T lymphocytes and a lower
CD4:CD8 ratio in the examined patients than in the
control group (Tables 2 and 4). The results obtained for
the GS patient were characterized by the almost total
absence of B lymphocytes (0.47%, 12 cells/µl) and the
presence of CD4 and CD8 double-positive cells
(16.04%, 410 cells/µl). Patients nos. 2–9 had low B cell
percentages and patients nos. 4, 5, 8, and 10 had invert-
ed CD4:CD8 ratios (Table 1), but without full-sympto-
matic GS and without hypogammaglobulinemia.
In the thymectomized patients, the percentage of
CD4+ cells correlated significantly and positively with
the level of IgG (R=0.697, p<0.05). We found a nega-
tive correlation between the percentage of CD8+ cells
and the concentration of IgM (R=0.624, p=0.054). The
CD4:CD8 ratio correlated positively with the level of
IgG and IgM (R=0.612, R=0.624 and p=0.06, p=0.054,
respectively). There were no such correlations in the
healthy subjects.
The percentage of memory T cells was similar in
both groups. The percentages of CD4+ and CD8+
T lymphocytes expressing CD28 antigen were signifi-
cantly lower in the thymectomized patients than in the
healthy subjects (p<0.005 and p<0.01, respectively).
The percentage of naïve T-helper (Th) lymphocytes was
significantly lower in the examined patients than in the con-
trol group (Fig. 1). The thymectomized patients with MG
showed a slightly higher percentage of naïve CD8+ cells
with CD45RA antigen than the patients without MG and
the control subjects. The percentage of naïve CD4+ T cells
was slightly lower in both the MG-positive and the MG-
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)negative group of thymectomized patients than in the con-
trol group (Table 5).
DISCUSSION
The human thymus is the central lymphoid organ
that provides a specialized microenvironment for matu-
ration and selection for the majority of TCRαβ T lym-
phocytes. With increasing age, the lymphatic thymic
mass decreases and thymocyte production declines in
parallel (thymic involution) [17]. Recent data, and the
results of our investigation, suggest, however, that the
adult thymus can remain active even late in life, supply-
ing functional T cells to the periphery.
The appearance of autoimmunological disease and
immunodeficiencies in patients suffering from thymo-
ma, and in thymecomized subjects, indicates the impor-
tant role of the thymus in adults. Myasthenia gravis and
PRCA are occasionally associated with thymoma. MG
appears in about 20–40% of patients with thymoma and
PRCA develops in about 2–5% of those patients. On the
other hand, thymoma is detected in 10–17% of patients
with MG and in 5–13% of patients with PRCA [12]. 
Hypogammaglobulinemia and B-lymphopenia devel-
op in 3–6% patients with thymoma. According to Tarr et
al. [22], reviews of the literature identified 51 reports of
infections in GS patients. The infections included recur-
rent sinopulmonary infection most often developed by
Haemophilus influenzae, cytomegalovirus infection, bac-
teremia, oral or esophageal candidiasis, persistent muco-
cutaneous candidiasis, chronic diarrhea with document-
ed stool pathogens, urinary tract infections, Pneumocystis
carinii pneumonia, tuberculosis, Kaposi’s sarcoma, and
disseminated varicella. Patients with GS present a spec-
trum of sinopulmonary infections and pathogens similar
to common variable immunodeficiency (CVID).
Compared with patients with CVID, opportunistic infec-
tions, including severe cytomegalovirus disease,
Pneumocytsis carinii pneumonia, and mucocutaneous
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Table 2. Immunological characteristic of thymectomized patients
Patient Leuko- Lympho- CD19+ CD19+ CD4+ CD4+ CD8+ CD8+ IgG IgM  IgA 
no. cyte cyte  cells cells  cells  cells  cells  cells  (mg/dl) (mg/dl) (mg/dl)
(cells/ (%) (%) (cells/ (%) (cells/ (%) (cells/
mm3)m m 3)m m 3)m m 3)
1 5 900 39.6 0.64 15 26.56 620 44.42 1038 9 0 0
2 12 300 33.5 4.17 172 37.71 1554 37.03 1526 1213 305 277
3 5 700 34.1 7.73 150 43.37 843 33.93 660 1222 181 385
4 4 700 33.1 1.12 17 30.82 480 58.29 907 1313 205 174
5 8 000 28.6 4.38 100 36.33 831 52.36 1198 867 176 151
6 4 400 28.3 4.07 51 45.81 570 41.75 520 1507 111 323
7 8 000 16.1 7.75 100 46.62 600 33.00 425 1573 488 513
8 9 300 23.8 1.85 41 33.74 747 52.40 1160 1464 164 165
9 8 100 29.2 3.41 81 51.84 1226 33.09 782 1065 190 118
10 6 200 25.7 18.11 288 20.17 321 40.46 644 1936 211 409
11 11 200 17.7 19.73 391 38.87 770 28.50 565 1178 76 149
Mean 7 600 28.15 6.63 127 37.44 778 41.38 857 1213.4 191.5 242.2
SD 2 560 7.1 6.50 118 9.35 347 9.58 341 490.3 126.1 152.0
Table 3. Immunoglobulin levels in serum of examined subjects
Thymectomized Healthy Good’s Reference 
patients subjects syndrome range
patient
IgG (mg/dl) 1213.4±490.3 1623.1±511 9 900–1700
IgM (mg/dl) 191.5±126.1 107.5±81.5 0 50–320
IgA (mg/dl) 242.2±152.0 259.8±171.9 0 100–490
Table 4. Subtypes of lymphocytes in peripheral blood of thymectomized patients and healthy subjects
CD19+ cells CD3+ cells CD4+ cells CD8+ cells CD4+/CD8+ CD4:CD8 NK  cells
(%) (%) (%) (%) cells (%) ratio (%)
Thymectomized 6.63±4.84 77.79±12.22 37.44±9.34 41.38±8.57 3.08±4.51 0.93±0.37 13.39±5.93
patients
Healthy subjects 11.71±4.37 67.52±7.69 41.10±7.60 32.08±7.48 1.86±0.91 1.39±0.53 15.15±8.79candidiasis, appear to be more common in patients with
GS, and patients with GS may have a worse prognosis.
The development of bronchiectases was also quite fre-
quent in GS [13, 22]. In our patients, the pathogens were,
in part, normal commensals of the upper respiratory
tract. However, the manifestation of characteristic symp-
toms of the diseases and the appearance of immunolog-
ical disturbances justified us to diagnose recurrent
sinopulmonary infections in 8 patients.
Our data indicate that the occurrence of different
disorders connected with the abnormal thymic function
may be underestimated and more frequent than other
authors supposed. Thymectomy was the only marker that
the qualified patients to be in the group examined. Prior
to our examination, no immunodeficiency was diag-
nosed. However, thymoma patients without clinical
symptoms of immune deficiency would be a very impor-
tant control group that should be examined in the future. 
We suggest that the removal of the thymus is on a par
with the disorganized thymic cortical environment in thy-
moma in causing recurrent respiratory system infections
during immunodeficiency. This hypothesis should be ver-
ified in patients undergoing thymectomy for non-neo-
plastic histology, e.g. MG patients with thymic lympho-
follicular hyperplasia. However, we concluded that
thymectomized patients should be subjected to frequent
monitoring of respiratory system function (chest radiog-
raphy, PFT, microbiological analysis of opportunistic
infections) and of the appearance of immunological
abnormalities (measurement of immunologlobulin level,
flow cytometric analysis of PBL subsets, etc.). 
MG and infections in the course of thymoma before
surgical treatment were diagnosed in only two patients
(Table 1). Unfortunately, immunological system status
(peripheral T and B cell repertoire as well as the levels
of immunoglobulins) was not determined before our
investigation. The patients had no stressful operations
during observation. However, it is possible that thymec-
tomy may finally trigger, but not actually cause, an out-
break of clinical symptoms. 
An accurate and timely diagnosis of immunodefi-
ciency associated with thymectomy is important in order
to prevent further complications, which may result in
irreversible lung tissue destruction. In the case of our
patient with GS, treatment with intravenous immune
globulin was effective. In the follow-up examination the
patient maintained an IgG level above 550 mg/dl, but
IgA and IgM levels persisted below 10 mg/dl.
The causes of immunodeficiency in patients with
thymoma and in thymectomized subjects are still
obscure. CD4+ T-lymphopenia and an inversion of the
CD4:CD8 ratio have been found in GS patients with
hypogammaglobulinemia and B-lymphopenia [9, 22].
Hoffacker et al. [5] detected a significant increase in the
proportion of circulating CD45RA+CD8+ T cells in
patients with thymoma and MG compared with healthy
subjects. In contrast, the CD4+ subset of CD45RA+
T cells was not significantly altered in the blood of thy-
moma patients. The authors concluded that the increase
in the proportion of CD45RA+CD8+ cells is due to the
peripheralization of thymoma-derived mature T cells.
They suggested that these T cells contribute to the
peripheral autoimmune cascade that leads to myas-
thenic symptoms of muscle weakness [5].
Strobel et al. [20] showed that the MG status of
thymectomized patients was significantly associated
with distinct abnormalities of intratumoral thy-
mopoiesis. The percentage of mature naïve
CD45RA+CD4+ T cells was highly reduced in the blood of
thymoma patients without MG. A statistically significant
increase in the percentage of naïve CD8+ T cells was found
in both MG-positive and MG-negative thymoma patients.
Their results suggested that the spectrum of thymopoietic
incompetence in thymomas may extend not only to the
CD4, but also to the CD8 lineage [14, 20]. 
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Fig. 1. Phenotype of T-helper (CD4+) and T cytotoxic-suppressor
(CD8+) lymphocytes in peripheral blood of the examined subjects:
A – memory T cells (CD45RO+), B – CD28+ cells, C – naïve T cells
(CD45RA+).
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CSempowski et al. [18] determined the effect of
thymectomy in MG patients on the levels of peripheral
blood cells containing signal joint TCRδ excision circles
(TRECs), a molecular marker of recent thymic emi-
grants. The authors found that thymectomy resulted in
a fall in TREC-positive T cell concentrations when thy-
mopoiesis was active at the time of surgery, but had lit-
tle effect in patients when thymopoiesis was minimal. In
contrast, naïve phenotype T cell levels did not fall after
thymectomy, whereas memory phenotype T cell concentra-
tions rose after thymectomy. The authors raised the hypoth-
esis that the thymus is an endocrine organ, producing fac-
tors such as a leukemia-inhibitory factor and oncostatin
M that may play roles in modulating peripheral blood T cell
levels. An additional explanation for the lack of reduction
in TREC-positive T cells after thymectomy in certain
patients was the possibility that TREC-positive cells could
be generated extrathymically [18]. This hypothesis may
explain the role of thymic involution in healthy adults.
It is possible that autoreactive T cells in thymoma
may also suppress the development of erythroid precur-
sors in PRCA, and the maturation of eosinophils and
B lymphocytes in immunodeficiency syndromes. The
failure to produce B lymphocytes occurs at the stem cell
level, as pre-B cells could not be found in the bone mar-
row in GS patients. The relationship between thymoma,
T cell dysfunction, and abnormalities in hematopoietic
stem cells remains conjectural, especially since thymec-
tomy has little, if any, effect on the development of
immunological disturbances and on the coexisting con-
dition in patients with acquired immunodeficiency.
Moreover, in some cases the symptoms manifested after
removal of the thymoma [1, 4, 6, 16].
Our results confirmed the appearance of strong
and general T cell immunological disturbance in
patients after thymectomy. The mechanisms by which
autoantigen-specific T cells contribute to the patho-
genesis of paraneoplastic syndromes in patients after
thymectomy are currently unknown. Our investigation
may suggest the existence of an extrathymic center of
thymopoiesis or residual ectopic thymic tissue in the
neck that may not be excised during total thymectomy.
In the first case, the lack of a correctly functioning thy-
mus and the impairment of negative selection may be
responsible for the survival of autoreactive clones of
T lymphocytes. 
In the light of this theory, the appearance of
CD4+CD8+ double-positive cells in the peripheral
blood of some patients after thymectomy may be signif-
icant. Peripheral double-positive T cells could represent
thymocytes that have prematurely escaped from the thy-
mus [7]. This hypothesis may also be explained by the
decrease in the percentage of T cells with CD28 antigen.
Matsui et al. [10] found a higher level of peripheral
blood CD4+CD8+ double-positive cells in patients with
MG and thymoma. The CD4+CD8+ T cell level was
closely related to the clinical symptoms of MG within
one year after thymectomy. The anti-AChR antibodies
generally changed in parallel with the clinical state and
level of CD4+CD8+ double-positive lymphocytes [10].
Nagvekar et al. [15] described T cell clones reacting
against muscle acetylocholine receptors in MG with thy-
moma, and these clones expressed both CD4 and
CD8α antigens and had a Th0 cytokine profile, produc-
ing IL-4 and IFN-γ.
T cells from CD28-deficient mice had strongly
impaired proliferation in vitro after stimulation with
antibodies to the TCR. Similarly in vivo, CD28-deficient
mice exhibited impaired Th B cell responses, although
CD8+ cytotoxic T-lymphocyte induction appeared to be
normal. An abnormal humoral response in developing
this mechanism may explain the existence of immunod-
eficiency in GS patients [2, 19].
The existence of CD4+CD8+ double-positive cells in
the peripheral blood after surgical removal of the thy-
mus may also result from the abnormal maturation of
cells and the lack of elimination of immature lympho-
cytes in the thymus. The impairment of the thymus in
thymectomized patients seems to be connected with the
decrease in the percentage of T cells with CD28 antigen.
The question arises whether the hypothesis concerning
the development of autoreactive clones of T lympho-
cytes in thymoma is valid. We suggest that the disorga-
nized thymic cortical environment in thymoma, as well
as the absence of the thymus after thymectomy, might
merely fail to delete or tolerate potentially self-reactive
T cells. This may result in a condition where, in a patient
with a non-totally disorganized thymus, the symptoms of
immunological abnormalities do not manifest them-
selves and only appear after thymectomy. This also indi-
cates a possible, and perhaps dominant, role of the thy-
mus in autoreactive cell elimination in adults.
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Table 5. Flow cytometry analysis of naïve T cell subsets in the examined groups
Thymectomized Thymectomized  Control  subjects
patients with MG patients without MG
Percentage of  43.56±10.91 32.55±14.29 53.02±15.91
CD4+ cells with 
CD45RA antigen
Percentage of  86.32±7.64 76.06±9.15 81.30±9.92
CD8+ cells with 
CD45RA antigenREFERENCES
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